These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation. Wkly Epidemiol Rec; 2017 Oct; 92(41):612-7. PubMed ID: 29028166 [No Abstract] [Full Text] [Related]
24. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135. Boisier P; Djibo S; Sidikou F; Mindadou H; Kairo KK; Djibo A; Goumbi K; Chanteau S Trop Med Int Health; 2005 May; 10(5):435-43. PubMed ID: 15860090 [TBL] [Abstract][Full Text] [Related]
25. [Epidemiological notes: meningococcal meningitis of serogroup X in Niamey (Niger)]. Etienne J; Sperber G; Adamou A; Picq JJ Med Trop (Mars); 1990 Apr; 50(2):227-9. PubMed ID: 2117224 [TBL] [Abstract][Full Text] [Related]
26. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso. Vogel G Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241 [No Abstract] [Full Text] [Related]
27. Infectious disease. Hitting early, epidemic meningitis ravages Nigeria and Niger. Roberts L Science; 2009 Apr; 324(5923):20-1. PubMed ID: 19342555 [No Abstract] [Full Text] [Related]
28. Laboratory evaluation of a rapid diagnostic test for Neisseria meningitidis serogroup A. Terrade A; Collard JM; Nato F; Taha MK Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):460-1. PubMed ID: 23687106 [TBL] [Abstract][Full Text] [Related]
29. Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks? Roberts L Science; 2010 Dec; 330(6010):1466-7. PubMed ID: 21148362 [No Abstract] [Full Text] [Related]
30. Meningococcal disease control in countries of the African meningitis belt, 2014. Wkly Epidemiol Rec; 2015 Mar; 90(13):123-31. PubMed ID: 25816448 [No Abstract] [Full Text] [Related]
31. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559 [TBL] [Abstract][Full Text] [Related]
32. Patterns of meningococcal infection in Sudan with emergence of Neisseria meningitidis serogroup W135. Karsany MS; Elshayeb AA; Saeed ES; Elaagib R; Ibrahim SA; Elsamani E; Hussien K; Salih KM East Mediterr Health J; 2013 Oct; 19(10):843-6. PubMed ID: 24313147 [TBL] [Abstract][Full Text] [Related]
33. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine? Collard JM; Maman Z; Abani A; Mainasara HB; Djibo S; Yacouba H; Maitournam R; Sidikou F; Nicolas P; Rocourt J; Jusot JF Epidemiol Infect; 2011 Nov; 139(11):1656-60. PubMed ID: 21251346 [TBL] [Abstract][Full Text] [Related]
35. Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine. LaForce FM; Okwo-Bele JM Health Aff (Millwood); 2011 Jun; 30(6):1049-57. PubMed ID: 21653956 [TBL] [Abstract][Full Text] [Related]
36. The Changing Epidemiology of Meningococcal Disease. Cohn A; MacNeil J Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420 [TBL] [Abstract][Full Text] [Related]